With regard to South Korea, Novartis solved specific nicely-publicized allegations that it experienced made inappropriate payments to HCPs in South Korea by spherical tables and 3rd-party health-related journals. Novartis Korea allegedly transmitted incorrect honoraria to HCPs for spherical tables by healthcare journals in order to avoid compliance